GFA
MRK icon

Gallagher Fiduciary Advisors’s Merck MRK Stock Holding History

Gallagher Fiduciary Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$752K Sell
5,849
-107
-2% -$12.5K 0.02% 140
2026
Q1 		$716K Sell
5,956
-1,401
-19% -$162K 0.03% 112
2025
Q4 		$774K Sell
7,357
-426
-5% -$40K 0.03% 128
2025
Q3 		$653K Sell
7,783
-4,065
-34% -$335K 0.02% 118
2025
Q2 		$938K Buy
11,848
+1,129
+11% +$89.7K 0.04% 81
2025
Q1 		$962K Buy
10,719
+380
+4% +$35.5K 0.03% 87
2024
Q4 		$1.03M Buy
10,339
+3,500
+51% +$361K 0.2% 61
2024
Q3 		$777K Sell
6,839
-2,873
-30% -$341K 0.16% 70
2024
Q2 		$1.2M Buy
9,712
+1,485
+18% +$191K 0.27% 44
2024
Q1 		$1.09M Buy
8,227
+197
+2% +$24.3K 0.04% 55
2023
Q4 		$875K Buy
8,030
+32
+0.4% +$3.32K 0.03% 59
2023
Q3 		$823K Sell
7,998
-194
-2% -$20.9K 0.07% 57
2023
Q2 		$946K Sell
8,192
-386
-4% -$43.8K 0.07% 63
2023
Q1 		$913K Buy
+8,578
New +$926K 0.08% 70

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Gallagher Fiduciary Advisors's MRK Position: Q2 2026 in Review

Gallagher Fiduciary Advisors reduced its Merck (MRK) stake by 1.8% in Q2 2026, selling an estimated $12.5K and leaving 5,849 shares worth $752K. The position accounts for 0.02% of the portfolio, ranked #140.

Gallagher Fiduciary Advisors first reported a position in MRK in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.2M in Q2 2024. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Gallagher Fiduciary Advisors held 5,849 shares of Merck worth $752K as of Q2 2026.
  • Gallagher Fiduciary Advisors sold 107 Merck shares in Q2 2026, an estimated $12.5K.
  • Merck made up 0.02% of Gallagher Fiduciary Advisors's portfolio in Q2 2026, its #140 holding.
  • Gallagher Fiduciary Advisors first reported a position in Merck in Q1 2023 and has held it in 14 quarters since.
  • Gallagher Fiduciary Advisors's Merck position peaked at $1.2M in Q2 2024.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Gallagher Fiduciary Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.